Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine in St Louis, St Louis, Missouri, USA.
Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine in St Louis, St Louis, Missouri, USA.
Otolaryngol Head Neck Surg. 2021 Dec;165(6):798-808. doi: 10.1177/01945998211004270. Epub 2021 Apr 13.
This is the first database study to assess the effectiveness of prophylactic preoperative antibiotics (PPAs) in mandible fracture repair.
Retrospective cohort.
Database study using US inpatient and outpatient insurance claims submitted from July 2006 to March 2015.
The IBM MarketScan Commercial Database was queried for adults aged 18 to 64 years who had undergone first-time mandible fracture repair according to codes for open and closed repair. Primary outcomes included surgical revision, local infection, and osteomyelitis. Rates were compared between cohorts based on whether or not patients had filled antibiotic prescriptions during the preoperative period alone. The effects of drug abuse and type of mandible repair (open vs closed) were explored. Multivariate Poisson regression models were used to calculate adjusted relative risk estimates, and 95% CIs were used to determine statistically significant differences.
A total of 2676 patients were included, with 847 (31.7%) filling PPAs and 1829 (68.3%) filling no antibiotics. Rates were 38.9% for revision, 5.8% for local infection, and 2.1% for osteomyelitis. After multivariate analysis, exposure to PPAs was not associated with surgical revision (adjusted relative risk, 1.04; 95% CI, 0.94-1.15), local infection (1.16; 0.82-1.64), or osteomyelitis (1.21; 0.68-2.14). Patients were more likely to fill PPAs if they underwent open repair (35.3%) versus closed (26.6%) (proportion difference, 8.7%; 95% CI, 5.2%-12.2%), but exposure to antibiotics did not predict outcomes on subgroup analysis.
PPAs do not improve mandible repair outcomes, regardless of repair type.
这是第一项评估预防性术前抗生素(PPA)在下颌骨骨折修复中的有效性的数据库研究。
回顾性队列研究。
使用美国 2006 年 7 月至 2015 年 3 月期间提交的住院和门诊保险索赔的数据库进行研究。
使用 IBM MarketScan 商业数据库,根据开放性和闭合性修复的代码,查询 18 至 64 岁接受首次下颌骨骨折修复的成年人。主要结果包括手术修正、局部感染和骨髓炎。根据患者是否在术前单独服用抗生素,比较两组之间的发生率。还探讨了药物滥用和下颌骨修复类型(开放性与闭合性)的影响。使用多变量泊松回归模型计算调整后的相对风险估计,95%置信区间用于确定统计学上的显著差异。
共纳入 2676 例患者,其中 847 例(31.7%)服用 PPA,1829 例(68.3%)未服用抗生素。修正率为 38.9%,局部感染率为 5.8%,骨髓炎率为 2.1%。经过多变量分析,暴露于 PPA 与手术修正(调整后的相对风险,1.04;95%置信区间,0.94-1.15)、局部感染(1.16;0.82-1.64)或骨髓炎(1.21;0.68-2.14)无关。如果患者接受开放性修复(35.3%)而不是闭合性修复(26.6%),则更有可能服用 PPA(比例差异,8.7%;95%置信区间,5.2%-12.2%),但抗生素暴露在亚组分析中并未预测结果。
无论修复类型如何,PPA 都不能改善下颌骨修复的结果。